Literature DB >> 18639213

Peripartum Clostridium difficile infection: case series and review of the literature.

Kevin W Garey1, Zhi-Dong Jiang, Yashoo Yadav, Bridget Mullins, Keith Wong, Herbert L Dupont.   

Abstract

Clostridium difficile infection (CDI) in nonhospitalized patients has been reported with increased frequency. An association between CDI and pregnancy has not been stressed. This review will report 4 cases of peripartum CDI with characterization of the infecting strain and a literature review. A PubMed search identified 24 recorded cases of peripartum CDI; information was available for 14 cases. Most patients (91%) received prophylactic antibiotics during delivery or for treatment of bacterial infections (50%). All patients reported diarrhea. Two of our reported cases without known risk factors were found by polymerase chain reaction analysis to be infected with an epidemic and hypervirulent C difficile strain. These cases demonstrate the need for clinicians to consider CDI in patients with severe diarrhea, even if they do not have the traditional risk factors for CDI, such as antibiotic use or concurrent hospitalizations. Further research into the scope and risk factors for peripartum CDI is warranted.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18639213     DOI: 10.1016/j.ajog.2008.05.001

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

Review 1.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  EP4 and EP2 receptor activation of protein kinase A by prostaglandin E2 impairs macrophage phagocytosis of Clostridium sordellii.

Authors:  Lisa M Rogers; Tennille Thelen; Krystle Fordyce; Emilie Bourdonnay; Casey Lewis; Han Yu; Junyong Zhang; Jingli Xie; Carlos H Serezani; Marc Peters-Golden; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2013-08-01       Impact factor: 3.886

3.  Underestimation of Clostridium difficile infection among clinicians: an international survey.

Authors:  M N Mavros; V G Alexiou; K Z Vardakas; K Tsokali; T A Sardi; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-27       Impact factor: 3.267

Review 4.  Variable spectrum of disease and risk factors of peripartum Clostridium difficile infection: report of 14 cases from French hospitals and literature review.

Authors:  Claire de Curraize; Clotilde Rousseau; Stéphane Corvec; Najoua El-Helali; Vincent Fihman; Frédéric Barbut; Anne Collignon; Alban Le Monnier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-03       Impact factor: 3.267

5.  Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions.

Authors:  V K Viswanathan; M J Mallozzi; Gayatri Vedantam
Journal:  Gut Microbes       Date:  2010-06-16

Review 6.  Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.

Authors:  Laura Armengol Álvarez; Greet Van de Sijpe; Stefanie Desmet; Willem-Jan Metsemakers; Isabel Spriet; Karel Allegaert; Jef Rozenski
Journal:  Antibiotics (Basel)       Date:  2022-05-21

7.  The emergence of Clostridium difficile infection among peripartum women: a case-control study of a C. difficile outbreak on an obstetrical service.

Authors:  Jennifer A Unger; Estella Whimbey; Michael G Gravett; David A Eschenbach
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-24

Review 8.  Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread.

Authors:  Archie C A Clements; Ricardo J Soares Magalhães; Andrew J Tatem; David L Paterson; Thomas V Riley
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

9.  Outcomes of Continuous Enteral Vancomycin Infusion in Intensive Care Unit Patients: A Novel Treatment Modality for Severe Clostridium Difficile Colitis.

Authors:  Haley Peters; Arslan Iqbal; Emily Miller; Sana Khalid; Omar Rahman
Journal:  Cureus       Date:  2022-03-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.